| BALCX | RLBAX | BALCX / RLBAX | |
| Total Expense Ratio | 1.30 | 1.32 | 98% |
| Annual Report Gross Expense Ratio | 1.30 | 1.32 | 98% |
| Fund Existence | 25 years | 24 years | - |
| Gain YTD | 7.581 | 7.557 | 100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 288B | 288B | 100% |
| Annual Yield % from dividends | 1.14 | 1.11 | 102% |
| Returns for 1 year | 9.67 | 9.65 | 100% |
| Returns for 3 years | 35.15 | 35.09 | 100% |
| Returns for 5 years | 27.98 | 27.88 | 100% |
| Returns for 10 years | 72.05 | 71.86 | 100% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MCYVX | 16.34 | 0.11 | +0.68% |
| NYLI Candriam Emerging Markets Eq Inv Cl | |||
| FSDAX | 28.34 | N/A | N/A |
| Fidelity Select Defense & Aerospace | |||
| TRBCX | 208.90 | N/A | N/A |
| T. Rowe Price Blue Chip Growth | |||
| BIAUX | 32.15 | N/A | N/A |
| Brown Advisory Small-Cap Fdmtl Val Inv | |||
| GRGUX | 55.70 | N/A | N/A |
| Goldman Sachs Equity Income R6 | |||